AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided … – 4-traders (press release)

AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided
4-traders (press release)
Aerocrine AB (STO:AERO-B) – A new randomised clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment. The study has been published on 

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.